NCT07096674View on ClinicalTrials.gov

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Interventions
DRUG

ORX750

Oral ORX750

DRUG

ORX750

Oral ORX750

DRUG

ORX750

Oral ORX750

Trial Locations (1)

28070

RECRUITING

Site Number 1, Huntersville

Sponsors
All Listed Sponsors
lead

Centessa Pharmaceuticals (UK) Limited

INDUSTRY